Adjuvant Trials

 
1. Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC     

  

                     ClinicalTrials.gov Identifier                                NCT02273375           

The purpose of this study is to find out whether it is better to receive a new drug, MEDI4736, or better to receive no further treatment after surgery (possibly chemotherapy) for lung cancer.   

Newfoundland
Dr. H. Bliss Murphy Cancer Centre
St. Johns, Newfoundland and Labrador, A1B 3V6

Ontario
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2 

Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, K7L 5P9

Lakeridge Health Oshawa
Oshawa, Ontario, L1G 2B9

Ottawa Hospital Research Institute 
Ottawa, Ontario, K1H 8L6

Algoma District Cancer Program
Sault Ste. Marie, Ontario, P6B 0A8

Niagara Health System
St. Catharines, Ontario, L2S 0A9

Health Sciences North
Sudbury, Ontario, P3E 5J1

Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, P7B 6V4

Mount Sinai Hospital
Toronto, Ontario, M5G 1X5

Univ. Health Network - Princess Margaret Hospital 
Toronto, Ontario, M5G 2M9

Quebec
McGill University - Dept. Oncology 
Montreal, Quebec, H2W 1S6

Saskatchewan 
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1

Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4

Alberta
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2

Tom Baker Cancer Center
Calgary, Alberta, T2N 4N2

Nova Scotia 
QE II Health Sciences Center 
Halifax, Nova Scotia, B3H 2Y9
 
2. AZD9291 Versus Placebo in Patients with Stage IB-IIIA Non-small Cell Lung Carcinoma, Folowing Complete Tumour Resection With or Without Adjuvant Chemotherapy (ADAURA) 
 
            ClinicalTrials.gov Identifier                       NCT02273375            

 
A Phase III, Double-blind, Randomized, Placebo-controlled Multi-centre, Study to Assess the Efficacy and Safety of AZD9291 Versus Placebo, in Patients with Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (ADAURA)

New Brunswick
Moncton

Ontario
Brampton